InvestSMART

Nyrada Inc (ASX: NYR) - Announcements

Current share price for NYR : $0.510 0.035 (6.42%)+

ASX company news and announcements for Nyrada Inc (NYR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nyrada Inc (NYR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nyrada Inc (NYR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nyrada Inc (NYR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$132 Change of Director's Interest Notice - RW 20 Feb 2026 5:06PM $0.580 $0.510 fallen by 12.07%
$132 Change of Director's Interest Notice - MF 20 Feb 2026 5:06PM $0.580 $0.510 fallen by 12.07%
$132 Change of Director's Interest Notice - JM 20 Feb 2026 5:06PM $0.580 $0.510 fallen by 12.07%
$132 Change of Director's Interest Notice - ID 20 Feb 2026 5:05PM $0.580 $0.510 fallen by 12.07%
$132 Change of Director's Interest Notice - CC 20 Feb 2026 5:05PM $0.580 $0.510 fallen by 12.07%
$132 Notification regarding unquoted securities - NYR 20 Feb 2026 4:49PM $0.580 $0.510 fallen by 12.07%
$132 Capital Structure Update 18 Feb 2026 2:08PM $0.620 $0.510 fallen by 17.74%
$132 Top 20 CDI Holder List 18 Feb 2026 2:05PM $0.620 $0.510 fallen by 17.74%
$132 Nyrada Half Year FY2026 Results 18 Feb 2026 2:02PM $0.620 $0.510 fallen by 17.74%
$132 Appendix 4D and Half Year Report to 31 December 2025 18 Feb 2026 1:58PM $0.650 $0.510 fallen by 21.54%
$132 Cleansing Statement 5 Feb 2026 5:17PM $0.820 $0.510 fallen by 37.80%
$132 Application for quotation of securities - NYR 5 Feb 2026 5:15PM $0.820 $0.510 fallen by 37.80%
$132 Investor Update Webinar 5 Feb 2026 8:21AM $0.920 $0.510 fallen by 44.57%
$132 Nyrada Phase IIa Clinical Trial Factsheet 5 Feb 2026 8:21AM $0.920 $0.510 fallen by 44.57%
$132 Change in substantial holding - Matt Corp WA PL 29 Jan 2026 4:57PM $0.840 $0.510 fallen by 39.29%
$132 Change in substantial holding - M Azzi 29 Jan 2026 4:51PM $0.840 $0.510 fallen by 39.29%
$132 Update to Nyrada Substantial Holders 29 Jan 2026 4:45PM $0.840 $0.510 fallen by 39.29%
$132 Nyrada Investor Webinar 28 Jan 2026 4:34PM $0.880 $0.510 fallen by 42.05%
$132 Cleansing Statement 23 Jan 2026 2:23PM $1.025 $0.510 fallen by 50.24%
$132 Application for quotation of securities - NYR 23 Jan 2026 2:22PM $1.025 $0.510 fallen by 50.24%
$132 Quarterly Activities Report and Appendix 4C 23 Jan 2026 8:52AM $0.935 $0.510 fallen by 45.45%
$132 Change of Director's Interest Notice - ID 19 Jan 2026 1:28PM $1.000 $0.510 fallen by 49%
$132 Notification of cessation of securities - NYR 19 Jan 2026 8:29AM $0.945 $0.510 fallen by 46.03%
$132 Cleansing Statement 13 Jan 2026 5:46PM $1.075 $0.510 fallen by 52.56%
$132 Application for quotation of securities - NYR 13 Jan 2026 5:44PM $1.075 $0.510 fallen by 52.56%

51 - 75 of 514 results

Page 3 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.